AGM/EGMApr 29, 2026, 08:02 AM
CNTA 2026 AGM on June 12; Directors & Auditors Re-appointment
AI Summary
Centessa Pharmaceuticals plc announced its 2026 Annual General Meeting (AGM) will be held on Friday, June 12, 2026, in London. Shareholders will vote on the re-appointment of three directors, the re-appointment and ratification of KPMG LLP as auditors, and the authorization of auditor remuneration. The AGM will also cover the receipt and adoption of 2025 UK statutory annual accounts and reports, and advisory approval of the directors' remuneration report, noting no dividend payment for 2025. This AGM is separate from special meetings related to the previously announced acquisition by Eli Lilly.
Key Highlights
- 2026 Annual General Meeting (AGM) scheduled for Friday, June 12, 2026, at 2:30 p.m. London time.
- Shareholders to vote on re-appointing Carol Stuckley, Brett Zbar, and Mathias Hukkelhoven as directors.
- Proposals include re-appointing KPMG LLP as UK statutory auditors and ratifying them as independent registered public accounting firm for 2026.
- Audit Committee to be authorized to determine auditors' remuneration for the financial year ending December 31, 2026.
- Receipt and adoption of 2025 UK statutory annual accounts and reports, with no dividend recommended for 2025.
- Advisory approval of the Company's UK statutory directors' remuneration report for the financial year ended December 31, 2025.
- AGM is separate from special meetings for the previously announced Eli Lilly acquisition.
Price Impact
More from CNTA